Health Care [ 9/12 ] | Biotechnology [ 45/74 ]
NASDAQ | Common Stock
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.
Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed phase 1 trial for undisclosed seizure disorder and is in phase 2 clinical trials for the developmental and epileptic encephalopathies and absence epilepsies.
The company also develops BMB-201 and BMB-202 for the treatment of neuropsychiatric and neurology indications; and BMB-105, a 5-HT2C agonist to treat Prader Willi Syndrome.
Bright Minds Biosciences Inc. has a collaboration with Firefly Neuroscience, Inc. to provide an analysis of the electroencephalogram (EEG) data in the Company's BREAKTHROUGH study.
The company was founded in 2017 and is headquartered in New York, New York.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Sep 30, 25 | -0.58 Decreased by -241.18% | -1.00 Increased by +41.85% |
| Aug 14, 25 | -0.74 Decreased by -2.15 K% | -0.88 Increased by +16.10% |
| May 15, 25 | -0.42 Decreased by -340.25% | -0.46 Increased by +8.70% |
| Feb 13, 25 | 0.01 Increased by +103.11% | -0.50 Increased by +102.00% |
| Nov 27, 24 | -0.17 Increased by +43.71% | -0.60 Increased by +71.67% |
| Aug 15, 24 | 0.04 Increased by +112.54% | - |
| May 14, 24 | -0.10 Decreased by -19.10% | - |
| Feb 12, 24 | -0.32 Decreased by -235.56% | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 25 | 0.00 Decreased by N/A% | -2.93 M Decreased by -291.49% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 25 | 0.00 Decreased by N/A% | -5.24 M Decreased by -2.54 K% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 25 | 0.00 Decreased by N/A% | -2.95 M Decreased by -413.88% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 24 | 0.00 Decreased by N/A% | 49.61 K Increased by +102.95% | Increased by +N/A% Decreased by N/A% |
| Sep 30, 24 | 0.00 Decreased by N/A% | -749.32 K Increased by +50.96% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | 214.92 K Increased by +114.74% | Increased by +N/A% Decreased by N/A% |
| Mar 31, 24 | 0.00 Decreased by N/A% | -574.14 K Increased by +72.00% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 23 | 0.00 Decreased by N/A% | -1.68 M Increased by +27.88% | Decreased by N/A% Decreased by N/A% |